Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Lovering, Richard M ^a   De Deyne, Patrick G ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Synthes Technical Center   (United States)

Author keywords

Cytoskeleton; Dystrophin; Muscle injury; Sarcolemma

Indexed keywords

ACTIN; ALPHA ACTIN; DESMIN; DYSTROPHIN; FIBRONECTIN; LAMININ; MYOSIN; SPECTRIN; SPECTRIN BETA SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOSKELETON; FORCE TRANSDUCER; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MALE; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; SARCOLEMMA; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALIA;

EID: 0742288186     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00199.2003     Document Type: Article

References (57)

1. Alderton JM and Steinhardt RA. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 10: 268-272, 2000.
2. Armstrong SC, Latham CA, Shivell CL, and Ganote CE. Ischemic loss of sarcolemmal dystrophin and spectrin: correlation with myocardial injury. J Mol Cell Cardiol 33: 1165-1179, 2001.
3. Augier N, Leger J, Robert A, Pons F, Leger JJ, and Mornet D. Proteolytic susceptibility of the central domain in chicken gizzard and skeletal muscle dystrophins. Biochim Biophys Acta 1138: 297-304, 1992.
4. Badorff C, Berkely N, Mehrotra S, Talhouk JW, Rhoads RE, and Knowlton KU. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 275: 11191-11197, 2000.
5. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, and Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5: 320-326, 1999.
6. Barash IA, Peters D, Friden J, Lutz GJ, and Lieber RL. Desmin cytoskeletal modifications after a bout of eccentric exercise in the rat. Am J Physiol Regul Integr Comp Physiol 283: R958-R963, 2002.
7. Bies RD, Caskey CT, and Fenwick R. An intact cysteine-rich domain is required for dystrophin function. J Clin Invest 90: 666-672, 1992.
8. Biral D, Jakubiec-Puka A, Ciechomska I, Sandri M, Rossini K, Carraro U, and Betto R. Loss of dystrophin and some dystrophin-associated proteins with concomitant signs of apoptosis in rat leg muscle overworked in extension. Acta Neuropathol (Berl) 100: 618-626, 2000.
9. Brooks SV, Zerba E, and Faulkner JA. Injury to muscle fibres after single stretches of passive and maximally stimulated muscles in mice. J Physiol 488: 459-469, 1995.
10. Cannon JG, Orencole SF, Fielding RA, Meydani M, Meydani SN, Fiatarone MA, Blumberg JB, and Evans WJ. Acute phase response in exercise: interaction of age and vitamin E on neutrophils and muscle enzyme release. Am J Physiol Regul Integr Comp Physiol 259: R1214-R1219, 1990.
11. Chopard A, Pons F, and Marini JF. Cytoskeletal protein contents before and after hindlimb suspension in a fast and slow rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol 280: R323-R330, 2001.
12. Cohn RD and Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 23: 1456-1471, 2000.
13. Cottin P, Poussard S, Mornet D, Brustis JJ, Mohammadpour M, Leger J, and Ducastaing A. In vitro digestion of dystrophin by calcium-dependent proteases, calpains I and II. Biochimie 74: 565-570, 1992.
14. Cullen MJ, Walsh J, Nicholson LV, Harris JB, Zubrzycka-Gaarn EE, Ray PN, and Worton RG. Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus. Neuromuscul Disord 1: 113-119, 1991.
15. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der MJ, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, and Campbell KP. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471, 1998.
16. Ervasti JM and Campbell KP. Dystrophin and the membrane skeleton. Curr Opin Cell Biol 5: 82-87, 1993.
17. Faulkner JA, Brooks SV, and Opiteck JA. Injury to skeletal muscle fibers during contractions: conditions of occurrence and prevention. Phys Ther 73: 911-921, 1993.
18. Friden J and Lieber RL. Serum creatine kinase level is a poor predictor of muscle function after injury. Scand J Med Sci Sports 11: 126-127, 2001.
19. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, and McNally EM. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142: 1279-1287, 1998.
20. Hamer PW, McGeachie JM, Davies MJ, and Grounds MD. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 200: 69-79, 2002.
21. Harlow E and Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1988, p. 471-504.
22. Hoffman EP, Brown RH Jr, and Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987.
23. Hori S, Ohtani S, Nguyen TM, and Morris GE. The N-terminal half of dystrophin is protected from proteolysis in situ. Biochem Biophys Res Commun 209: 1062-1067, 1995.
24. Hunter KD and Faulkner JA. Pliometric contraction-induced injury of mouse skeletal muscle: effect of initial length. J Appl Physiol 82: 278-283, 1997.
25. Koenig M and Kunkel LM. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem 265: 4560-4566, 1990.
26. Komulainen J, Takala TE, Kuipers H, and Hesselink MK. The disruption of myofibre structures in rat skeletal muscle after forced lengthening contractions. Pflügers Arch 436: 735-741, 1998.
27. Komulainen J, Takala TE, and Vihko V. Does increased serum creatine kinase activity reflect exercise-induced muscle damage in rats? Int J Sports Med 16: 150-154, 1995.
28. Lapointe BM and Cote CH. Anesthetics can alter subsequent in vitro assessment of contractility in slow and fast skeletal muscles of rat. Am J Physiol Regul Integr Comp Physiol 277: R917-R921, 1999.
29. Li Z, Mericskay M, Agbulut O, Butler-Browne G, Carlsson L, Thornell LE, Babinet C, and Paulin D. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 139: 129-144, 1997.
30. Lieber RL and Friden J. Muscle damage is not a function of muscle force but active muscle strain. J Appl Physiol 74: 520-526, 1993.
31. Lieber RL, Schmitz MC, Mishra DK, and Friden J. Contractile and cellular remodeling in rabbit skeletal muscle after cyclic eccentric contractions. J Appl Physiol 77: 1926-1934, 1994.
32. Lynch GS and Faulkner JA. Contraction-induced injury to single muscle fibers: velocity of stretch does not influence the force deficit. Am J Physiol Cell Physiol 275: C1548-C1554, 1998.
33. Lynch GS, Rafael JA, Chamberlain JS, and Faulkner JA. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am J Physiol Cell Physiol 279: C1290-C1294, 2000.
34. MacIntyre DL, Reid WD, Lyster DM, Szasz LI, and McKenzie DC. Presence of WBC, decreased strength, and delayed soreness in muscle after eccentric exercise. J Appl Physiol 80: 1006-1013, 1996.
35. Malm C, Nyberg P, Engstrom M, Sjodin B, Lenkei R, Ekblom B, and Lundberg I. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 529: 243-262, 2000.
36. Matsuda R, Nishikawa A, and Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem (Tokyo) 118: 959-964, 1995.
37. McNeil PL and Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-1109, 1992.
38. Morgan DL and Allen DG. Early events in stretch-induced muscle damage. J Appl Physiol 87: 2007-2015, 1999.
39. Nosaka K and Clarkson PM. Relationship between post-exercise plasma CK elevation and muscle mass involved in the exercise. Int J Sports Med 13: 471-475, 1992.
40. Oblendieck K. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol 69: 1-10, 1996.
41. Patel TJ and Lieber RL. Force transmission in skeletal muscle: from actomyosin to external tendons. Exerc Sport Sci Rev 25: 321-363, 1997.
42. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
43. Sakuraba H, Hori S, Ohtani S, Hanaka S, Abe T, Shimmoto M, and Suzuki Y. A case of Duchenne muscular dystrophy with truncated dystrophin. Significance of a cysteine-rich domain for functional expression of dystrophin protein. Brain Dev 15: 222-225, 1993.
44. Sam M, Shah S, Friden J, Milner DJ, Capetanaki Y, and Lieber RL. Desmin knockout muscles generate lower stress and are less vulnerable to injury compared with wild-type muscles. Am J Physiol Cell Physiol 279: C1116-C1122, 2000.
45. Spencer MJ, Croall DE, and Tidball JG. Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 270: 10909-10914, 1995.
46. St Pierre SB, Brickson S, Corr DT, and Best T. CD11b+ neutrophils predominate over RAM11+ macrophages in stretch-injured muscle. Muscle Nerve 25: 837-844, 2002.
47. Straub V, Rafael JA, Chamberlain JS, and Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139: 375-385, 1997.
48. Street SF and Ramsey RW. Sarcolemma: transmitter of active tension in frog skeletal muscle. Science 149: 1379-1380, 1965.
49. Thompson JL, Balog EM, Fitts RH, and Riley DA. Five myofibrillar lesion types in eccentrically challenged, unloaded rat adductor longus muscle-a test model. Anat Rec 254: 39-52, 1999.
50. Tidball JG. Force transmission across muscle cell membranes. J Biomech 24: 43-52, 1991.
51. Tidball JG. Interactions between muscle and the immune system during modified musculoskeletal loading. Clin Orthop S100-S109, 2002.
52. Tidball JG, Berchenko E, and Frenette J. Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol 65: 492-498, 1999.
53. Tidball JG and Spencer MJ. Calpains and muscular dystrophies. Int J Biochem Cell Biol 32: 1-5, 2000.
54. Warren GL, Hayes DA, Lowe DA, and Armstrong RB. Mechanical factors in the initiation of eccentric contraction-induced injury in rat soleus muscle. J Physiol 464: 457-475, 1993.
55. Warren GL, Ingalls CP, Lowe DA, and Armstrong RB. Excitation-contraction uncoupling: major role in contraction-induced muscle injury. Exerc Sport Sci Rev 29: 82-87, 2001.
56. Yoshida M, Suzuki A, Shimizu T, and Ozawa E. Proteinase-sensitive sites on isolated rabbit dystrophin. J Biochem (Tokyo) 112: 433-439, 1992.
57. Zerba E, Komorowski TE, and Faulkner JA. Free radical injury to skeletal muscles of young, adult, and old mice. Am J Physiol Cell Physiol 258: C429-C435, 1990.